Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa

J Med Microbiol. 2008 Dec;57(Pt 12):1514-1517. doi: 10.1099/jmm.0.2008/001636-0.

Abstract

Chequerboard and time-kill methods were used to compare the in vitro efficacies of the combinations gatifloxacin (GAT) with cefoperazone (CFP) and GAT with cefoperazone-sulbactam (CFP-SUL) against 58 clinical isolates of Pseudomonas aeruginosa. The combinations GAT+CFP and GAT+CFP-SUL were shown to be synergistic for 36.2 and 58.6 % of isolates tested, respectively, using the chequerboard method. Time-kill studies with 11 strains showed synergy in 54.5 % for the GAT+CFP combination and 72.7 % for the GAT+CFP-SUL combination. The agreement between these two methods was found to be 72-81 %. There was a significant difference in synergy between the two combinations tested (P=0.011).

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cefoperazone / pharmacology*
  • Drug Resistance, Bacterial*
  • Drug Synergism
  • Drug Therapy, Combination
  • Fluoroquinolones / pharmacology*
  • Gatifloxacin
  • Humans
  • Microbial Sensitivity Tests / methods
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / growth & development
  • Sulbactam / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Cefoperazone
  • Gatifloxacin
  • Sulbactam